GH Research (NASDAQ:GHRS) Stock Quotes, Forecast and News Summary

Q: What sector and industry does GH Research (GHRS) operate in?

GH Research is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

GH Research Stock (NASDAQ: GHRS) stock price, news, charts, stock research, profile.

Open	-
Close	-
Volume / Avg.	2.00 / 63.03K
Day Range	- - -
52 Wk Range	5.05 - 14.99
Market Cap	$440.16M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	49
Short Interest	13.41%
Days to Cover	30.5

Recent News

3 Fast-Growing Stocks Analysts See Doubling in Price

Comparing and selecting stocks for investment may involve any number of increasingly complex strategies and approaches, but sometimes simpler is better: targeting a stock with significant upside potential at an

MarketBeat

Irish Biotech Firm GH Research Sees Cash Decline in Q2, Advances Psychedelic Drug Trials

Irish psychedelic biotech firm GH Research PLC (NASDAQ: GHRS) reported on Tuesday financial results for the second quarter ended June 30, 2024. Cash, cash equivalents, other financial assets and marketable securities were $204.5 million as of June 30, 2024, compared to cash, cash equivalents, other financial assets and marketable securities of $222.7 million as of December 31, 2023.The net loss was $10.4 million, or $0.20 loss per share, for the quarter that ended June 30, 2024, compared to the $7.7 million or $0.15 loss per share for the same quarter in 2023. The Dublin-based company also provided an update on its DMT-related drugs that are currently undergoing clinical trials.

Jelena Martinovic

Psyched: DEA Revisits Ban On Two Psychedelics, Farewell Russell Newcombe, Podcast Episode On Kanna & More

Lara Goldstein

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Jul

Sep

Nov

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.2

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	-
Close	-
Volume / Avg.	2.00 / 63.03K
Day Range	- - -
52 Wk Range	5.05 - 14.99
Market Cap	$440.16M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	49
Short Interest	13.41%
Days to Cover	30.5

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy GH Research (GHRS) stock?

You can purchase shares of GH Research (NASDAQ:GHRS) through any online brokerage.

View our list of the best stock brokerages

Who are GH Research (GHRS) competitors?

Other companies in GH Research’s space includes: Atea Pharmaceuticals (NASDAQ:AVIR), Third Harmonic Bio (NASDAQ:THRD), Theravance Biopharma (NASDAQ:TBPH), Zevra Therapeutics (NASDAQ:ZVRA) and SNDL (NASDAQ:SNDL).

What is the forecast, or price target, for GH Research (GHRS) stock?

GH Research has a consensus price target of $41.20.

What is the current price for GH Research (GHRS)?

The stock price for GH Research (NASDAQ: GHRS) is $8.46 last updated December 17, 2024 at 4:02 PM EST.

Does GH Research (GHRS) pay a dividend?

There are no upcoming dividends for GH Research.

When is GH Research (NASDAQ:GHRS) reporting earnings?

GH Research’s Q4 earnings are confirmed for Thursday, February 27, 2025.

Is GH Research (GHRS) going to split?

There is no upcoming split for GH Research.

What sector and industry does GH Research (GHRS) operate in?

GH Research is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

Comments

GH Research

GH Research (GHRS) Forecast